+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Reduced chronic hemolysis during high-dose vitamin E administration in Mediterranean-type glucose-6-phosphate dehydrogenase deficiency



Reduced chronic hemolysis during high-dose vitamin E administration in Mediterranean-type glucose-6-phosphate dehydrogenase deficiency



New England Journal of Medicine 303(8): 416-420



The observation that high-dose oral vitamin E supplementation (800 IU per day) improved red-cell survival in two rare disorders associated with increased red-cell susceptibility to oxidative stress prompted a similar trial in 23 patients with Mediterranean glucose-6-phosphate dehydrogenase (G6PD) deficiency. Three months of vitamin E administration resulted in decreased chronic hemolysis as evidenced by improved red-cell life span (P less than 0.025), with an improvement in red-cell half-life from 22.9 +/- 0.7 days to 25.1 +/- 0.6 days (mean +/- S.E.M.), increased hemoglobin concentration (P less than 0.001), and decreased reticulocytosis (P less than 0.001) as compared with base-line values. Evaluation after one year of vitamin E administration demonstrated sustained improvement in all these indexes. Controlled clinical trials of vitamin E supplementation may be warranted to examine its efficacy in ameliorating acute hemolytic crises or in reducing morbidity from neonatal jaundice in this relatively common genetic disorder.

(PDF emailed within 0-6 h: $19.90)

Accession: 000965212

Download citation: RISBibTeXText

PMID: 7393270

DOI: 10.1056/NEJM198008213030802


Related references

Reduced chronic hemolysis in Mediterranean glucose-6-phosphate dehydrogenase deficiency after vitamin E therapy. Progress in Clinical and Biological Research 34: 381-387, 1979

Reduced chronic hemolysis in mediterranean glucose 6 phosphate dehydrogenase deficiency after vitamin e therapy evaluation at 1 year. Clinical Research 28(2): 307A, 1980

High-dose vitamin E does not decrease the rate of chronic hemolysis in glucose-6-phosphate dehydrogenase deficiency. New England Journal of Medicine 308(17): 1014-1017, 1983

Shortened erythrocyte survival in chronic hemolytic disease due to glucose 6 phosphate dehydrogenase deficiency is not corrected by high dose vitamin e therapy. Clinical Research 30(2): 319A, 1982

Improved erythrocyte survival with combined vitamin E and selenium therapy in children with glucose-6-phosphate dehydrogenase deficiency and mild chronic hemolysis. Journal of pediatrics 108(4): 558-561, 1986

Chronic Hemolysis Associated With Glucose-6-Phosphate Dehydrogenase Deficiency. Journal of Laboratory and Clinical Medicine 63: 1002-1009, 1964

Primaquine induced hemolysis in glucose 6 phosphate dehydrogenase deficiency effect of vitamin e. Pediatric Research 13(4 PART 2): 442, 1979

Potential risks of hemolysis after short-term administration of analgesics in children with glucose-6-phosphate dehydrogenase deficiency. Journal of Pediatrics 159(6): 1023-1028, 2011

Spontaneous hemolysis in a patient with glucose-6-p-dehydrogenase deficiency (Mediterranean type) and heterozygote beta thalassemia. Die Medizinische Welt 24: 1091-1095, 1970

Spontaneous hemolysis in a patient with glucose 6 phosphate dehydrogenase defect mediterranean type and heterozygotic beta thalassemia. Medizinische Welt (24): 1091-1095, 1970

Gd(-) Carapicuiba, a rare glucose-6-phosphate dehydrogenase variant associated with moderate enzyme deficiency and chronic hemolysis. Brazilian Journal of Medical and Biological Research 24(2): 133-139, 1991

Gd negative carapicuiba a rare glucose 6 phosphate dehydrogenase variant associated with moderate enzyme deficiency and chronic hemolysis. Brazilian Journal of Medical & Biological Research 24(2): 133-140, 1991

Chronic hemolysis and reduced serum alpha tocopherol levels in glucose 6 phosphate dehydrogenase deficient kurdish and iraq males. Clinical Research 29(2): 264A, 1981

Chronic hemolysis and reduced serum alpha tocopherol levels in glucose 6 phosphate dehydrogenase deficient kurdish and iraqi males. American Journal Of Clinical Nutrition: 626, 1981

Low glucose-6-phosphate dehydrogenase enzyme activity level at the time of hemolysis in a male neonate with the African type of deficiency. Blood Cells, Molecules and Diseases 27(5): 918-923, 2002